Search Results

There are 11813 results for: content related to: Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV -1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily

  1. You have full text access to this OnlineOpen article
    Model-Based Once-Daily Darunavir/Ritonavir Dosing Recommendations in Pediatric HIV-1-Infected Patients Aged 3 to <12 Years

    CPT: Pharmacometrics & Systems Pharmacology

    Volume 4, Issue 7, July 2015, Pages: 406–414, A Brochot, TN Kakuda, T Van De Casteele, M Opsomer, FL Tomaka, A Vermeulen and P Vis

    Article first published online : 19 JUN 2015, DOI: 10.1002/psp4.44

  2. Steady-State Pharmacokinetic Interactions of Darunavir/Ritonavir With Lipid-Lowering Agent Rosuvastatin

    The Journal of Clinical Pharmacology

    Volume 52, Issue 6, June 2012, Pages: 922–931, Ms Divya Samineni, Dr Pankaj B. Desai, Dr Larry Sallans and Dr Carl J. Fichtenbaum

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270011407494

  3. You have free access to this content
    Pharmacokinetic interaction between etravirine or darunavir/ritonavir and artemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-period, randomized trial

    HIV Medicine

    Volume 14, Issue 7, August 2013, Pages: 421–429, TN Kakuda, R DeMasi, Y van Delft and P Mohammed

    Article first published online : 26 FEB 2013, DOI: 10.1111/hiv.12019

  4. Switching to darunavir/ritonavir 800/100 mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 8–15, Jade Ghosn, Laurence Slama, Aziza Chermak, Allal Houssaini, Sidonie Lambert-Niclot, Luminita Schneider, Erwan Fourn, Claudine Duvivier, Anne Simon, Eve Courbon, Robert Murphy, Philippe Flandre, Gilles Peytavin, Christine Katlama and for the RADAR Study Group

    Article first published online : 28 SEP 2012, DOI: 10.1002/jmv.23404

  5. Influence of SLCO1B1 Polymorphisms on the Drug-Drug Interaction Between Darunavir/Ritonavir and Pravastatin

    The Journal of Clinical Pharmacology

    Volume 52, Issue 11, November 2012, Pages: 1725–1738, Dr Christina L. Aquilante, Dr Jennifer J. Kiser, Dr Peter L. Anderson, Dr Uwe Christians, Dr Lisa A. Kosmiski, Ms Elizabeth B. Daily, Mr Keith L. Hoffman, Mr Charles W. Hopley, Ms Julie A. Predhomme, Mr Bjorn Schniedewind and Ms Maha S. Sidhom

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270011427907

  6. Darunavir/Ritonavir Pharmacokinetics Following Coadministration With Clarithromycin in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 48, Issue 1, January 2008, Pages: 60–65, Dr Vanith J. Sekar, Dr Sabrina Spinosa-Guzman, Mr El D. Paepe, Dr Martin D. Pauw, Mr Tony Vangeneugden, Dr Eric Lefebvre and Dr Richar M. W. Hoetelmans

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270007309706

  7. You have free access to this content
    Body fat distribution in HIV-infected patients treated for 96 weeks with darunavir/ritonavir monotherapy versus darunavir/ritonavir plus nucleoside reverse transcriptase inhibitors: the MONOI-ANRS136 Substudy

    HIV Medicine

    Volume 13, Issue 8, September 2012, Pages: 505–515, MA Valantin, S Kolta, P Flandre, M Algarte Genin, JL Meynard, D Ponscarme, L Slama, L Cuzin, E de Kerviler, R Inaoui and C Katlama

    Article first published online : 14 MAR 2012, DOI: 10.1111/j.1468-1293.2012.01004.x

  8. Pharmacokinetics of darunavir in fixed-dose combination with cobicistat compared with coadministration of darunavir and ritonavir as single agents in healthy volunteers

    The Journal of Clinical Pharmacology

    Volume 54, Issue 8, August 2014, Pages: 949–957, Thomas N. Kakuda, Magda Opsomer, Maarten Timmers, Koen Iterbeke, Tom Van De Casteele, Vera Hillewaert, Romana Petrovic and Richard M. W. Hoetelmans

    Article first published online : 26 MAR 2014, DOI: 10.1002/jcph.290

  9. The Effect of Lopinavir/Ritonavir and Darunavir/Ritonavir on the HIV Integrase Inhibitor S/GSK1349572 in Healthy Participants

    The Journal of Clinical Pharmacology

    Volume 51, Issue 2, February 2011, Pages: 237–242, Dr Ivy Song, Dr Sherene S. Min, Ms Julie Borland, Ms Yu Lou, Dr Shuguang Chen, Dr Parul Patel, Dr Toru Ishibashi and Dr Stephen C. Piscitelli

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270010371113

  10. You have free access to this content
    Pharmacokinetics of darunavir/ritonavir and ketoconazole following co-administration in HIV–healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 66, Issue 2, August 2008, Pages: 215–221, Vanitha J. Sekar, Eric Lefebvre, Martine De Pauw, Tony Vangeneugden and Richard M. Hoetelmans

    Article first published online : 8 APR 2008, DOI: 10.1111/j.1365-2125.2008.03191.x

  11. You have free access to this content
    Intracellular and plasma steady-state pharmacokinetics of raltegravir, darunavir, etravirine and ritonavir in heavily pre-treated HIV-infected patients

    British Journal of Clinical Pharmacology

    Volume 69, Issue 5, May 2010, Pages: 475–483, Rob Ter Heine, Jan Willem Mulder, Eric C. M. Van Gorp, Jiri F. P. Wagenaar, Jos H. Beijnen and Alwin D. R. Huitema

    Article first published online : 1 FEB 2010, DOI: 10.1111/j.1365-2125.2010.03634.x

  12. The Intelence aNd pRezista Once A Day Study (INROADS): a multicentre, single-arm, open-label study of etravirine and darunavir/ritonavir as dual therapy in HIV-1-infected early treatment-experienced subjects

    HIV Medicine

    Volume 16, Issue 5, May 2015, Pages: 288–296, PJ Ruane, C Brinson, M Ramgopal, R Ryan, B Coate, M Cho, TN Kakuda and D Anderson

    Article first published online : 14 JAN 2015, DOI: 10.1111/hiv.12211

  13. Pharmacokinetics of darunavir after administration of an oral suspension with low-dose ritonavir and with or without food

    Clinical Pharmacology in Drug Development

    Volume 3, Issue 5, September/October 2014, Pages: 346–352, Thomas N. Kakuda, Vanitha Sekar, Ludo Lavreys, Els De Paepe, Tanja Stevens, Marc Vanstockem, Tony Vangeneugden and Richard M.W. Hoetelmans

    Article first published online : 10 FEB 2014, DOI: 10.1002/cpdd.88

  14. Antiretroviral Pharmacokinetics in Pregnant Women

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 35, Issue 9, September 2015, Pages: 838–855, Elise M. Gilbert, Kristin M. Darin, Kimberly K. Scarsi and Milena M. McLaughlin

    Article first published online : 21 AUG 2015, DOI: 10.1002/phar.1626

  15. You have free access to this content
    British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review)

    HIV Medicine

    Volume 15, Issue S4, September 2014, Pages: 1–77,

    Article first published online : 25 SEP 2014, DOI: 10.1111/hiv.12185

  16. You have free access to this content
    Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study

    HIV Medicine

    Volume 12, Issue 5, May 2011, Pages: 299–307, J Young, AU Scherrer, HF Günthard, M Opravil, S Yerly, J Böni, M Rickenbach, CA Fux, M Cavassini, E Bernasconi, P Vernazza, B Hirschel, M Battegay, HC Bucher and for the Swiss HIV Cohort Study

    Article first published online : 18 OCT 2010, DOI: 10.1111/j.1468-1293.2010.00885.x

  17. The Effect of Different Meal Types on the Pharmacokinetics of Darunavir (TMC114)/Ritonavir in HIV-Negative Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 47, Issue 4, April 2007, Pages: 479–484, Dr Vanitha Sekar, Dr Dries Kestens, Dr Sabrina Spinosa-Guzman, Dr Martine De Pauw, Els De Paepe, Tony Vangeneugden, Dr Eric Lefebvre and Dr Richard M. W. Hoetelmans

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270006298603

  18. Virological response to darunavir in patients infected with HIV is linked to darunavir resistance–associated mutations corrected by the count of mutations with positive impact and is not associated with pharmacological and combined virological/pharmacological parameters

    Fundamental & Clinical Pharmacology

    Volume 26, Issue 4, August 2012, Pages: 538–542, Eric Dailly, Audrey Rodallec, Clotilde Allavena, Guillaume Deslandes, Elisabeth Garnier, Eric Billaud, Virginie Ferré, Véronique Reliquet, Régis Bouquié, François Raffi and Pascale Jolliet

    Article first published online : 5 MAY 2011, DOI: 10.1111/j.1472-8206.2011.00949.x

  19. You have free access to this content
    Effects of ritonavir-boosted darunavir vs. ritonavir-boosted atazanavir on lipid and glucose parameters in HIV-negative, healthy volunteers

    HIV Medicine

    Volume 10, Issue 5, May 2009, Pages: 318–327, F Tomaka, E Lefebvre, V Sekar, B Van Baelen, T Vangeneugden, A Vandevoorde and G Diego Miralles

    Article first published online : 5 FEB 2009, DOI: 10.1111/j.1468-1293.2008.00690.x

  20. Enhancing Protein Backbone Binding—A Fruitful Concept for Combating Drug-Resistant HIV

    Angewandte Chemie International Edition

    Volume 51, Issue 8, February 20, 2012, Pages: 1778–1802, Dr. Arun K. Ghosh, David D. Anderson, Dr. Irene T. Weber and Dr. Hiroaki Mitsuya

    Article first published online : 31 JAN 2012, DOI: 10.1002/anie.201102762